Demand for Self-Managed Online Telemedicine Abortion in the United States During the Coronavirus Disease 2019 (COVID-19) Pandemic

Obstet Gynecol. 2020 Oct;136(4):835-837. doi: 10.1097/AOG.0000000000004081.

Abstract

Increased demand for self-managed medication abortion in states with in-clinic restrictions or high infection rates during the coronavirus disease 2019 (COVID-19) pandemic demonstrates the need for remote abortion care models.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortifacient Agents / therapeutic use
  • Abortion, Induced* / methods
  • Abortion, Induced* / trends
  • Ambulatory Care Facilities / organization & administration*
  • Betacoronavirus
  • COVID-19
  • Change Management
  • Communicable Disease Control / methods
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / prevention & control
  • Female
  • Health Services Needs and Demand
  • Humans
  • Obstetrics / legislation & jurisprudence
  • Obstetrics / trends
  • Pandemics* / prevention & control
  • Pneumonia, Viral* / epidemiology
  • Pneumonia, Viral* / prevention & control
  • Policy Making
  • Pregnancy
  • SARS-CoV-2
  • Self-Management*
  • Telemedicine* / methods
  • Telemedicine* / organization & administration
  • United States

Substances

  • Abortifacient Agents